Bruce Bank

Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial

María‐Victoria Mateos, Hilary Blacklock, Fredrik Schjesvold et al. · The Lancet Haematology · 2019 · 253 citations · Full text

Medicine, Oncology, Pharmacology +12

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi et al. · The Lancet · 2023 · 185 citations

Medicine, Hematology, Pharmacology +9

A Comparison of Efficacy of Sargramostim (Yeast-Derived RhuGM-CSF) and Filgrastim (Bacteria-Derived RhuG-CSF) in the Therapeutic Setting of Chemotherapy-Induced Myelosuppression

Roy Beveridge, John A. Miller, Arthur N. Kales et al. · Cancer Investigation · 1998 · 64 citations

Medicine, Oncology, Pharmacotherapy +8

Chlorambucil pharmacokinetics and DNA binding in chronic lymphocytic leukemia lymphocytes.

Bruce Bank, D Kanganis, Leonard Liebes et al. · PubMed · 1989 · 55 citations

Medicine, Pharmacokinetics, Pharmacology +16

Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer

Randy F. Sweis, Sachdev Thomas, Bruce Bank et al. · Cureus · 2016 · 35 citations · Full text

Medicine, Molecular Medicine, Oncology +17